Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vitamin D3 Supplementation, Psychological Distress, Dyspepsia Burden and Heart Rate Variability in Adults With Functional Dyspepsia: A Single-Arm Pretest-Posttest Interventional Study

NCT07922473 is registered in ClinicalTrials.gov with Universitas Sebelas Maret Hospital as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07922473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Vitamin D3 Supplementation, Psychological Distress, Dyspepsia Burden and Heart Rate Variability in Adults With Functional Dyspepsia: A Single-Arm Pretest-Posttest Interventional Study
Lead sponsor
Universitas Sebelas Maret Hospital
Phase
Not applicable
Overall status
Completed
Start date
June 28, 2026
Completion date
October 20, 2026
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

functional dyspepsia

Arms

As registered; 1 arm.

  • Vitamin D3 ExperimentalCholecalciferol

    Oral colecalciferol (vitamin D3) 5,000 IU (125 micrograms) once daily for 30 days.

Primary endpoints

Registered primary outcome measures; 4 primary.

  • Change From Baseline in Nepean Dyspepsia Index (NDI) Total Score at Day 30 Baseline (Day 0) and Day 30

    Dyspepsia-related quality of life measured with the validated Indonesian version of the Nepean Dyspepsia Index (NDI), a self-administered questionnaire. Each of the 5 domains (tension/anxiety, interference with daily activities, eating/drinking, knowledge/control, work/study) is scored as the mean of its items, and the total score is the sum of the 5 domain scores. Minimum total score \[\[ISI: nilai minimum\]\], maximum total score \[\[ISI: nilai maksimum\]\]; higher scores indicate a worse outcome (greater dyspepsia-related impairment). Change is calculated as the Day 30 score minus the baseline score. Unit of measure: score on a scale.

  • Change From Baseline in Perceived Stress Scale-10 (PSS-10) Total Score at Day 30 Baseline (Day 0) and Day 30

    Perceived stress measured with the 10-item self-report Perceived Stress Scale (PSS-10), Indonesian version. Each item is scored 0 to 4; the total score ranges from 0 (minimum) to 40 (maximum), and higher scores indicate a worse outcome (greater perceived stress). Change is calculated as the Day 30 score minus the baseline score. Unit of measure: score on a scale.

  • Change From Baseline in State-Trait Anxiety Inventory State Anxiety (STAI-S) Score at Day 30 Baseline (Day 0) and Day 30

    State anxiety measured with the 20-item state form of the State-Trait Anxiety Inventory (STAI-S). Each item is scored 1 to 4; the total score ranges from 20 (minimum) to 80 (maximum), and higher scores indicate a worse outcome (greater state anxiety). Change is calculated as the Day 30 score minus the baseline score. Unit of measure: score on a scale.

  • Change From Baseline in State-Trait Anxiety Inventory Trait Anxiety (STAI-T) Score at Day 30 Baseline (Day 0) and Day 30

    Trait anxiety measured with the 20-item trait form of the State-Trait Anxiety Inventory (STAI-T). Each item is scored 1 to 4; the total score ranges from 20 (minimum) to 80 (maximum), and higher scores indicate a worse outcome (greater trait anxiety). Change is calculated as the Day 30 score minus the baseline score. Unit of measure: score on a scale.

Lead sponsor's other trials

Universitas Sebelas Maret Hospital, most recent start first.

Similar trials

Same condition (Anxiety Disorders) and phase, most recent start first.